精密科学(EXAS)
搜索文档
Exact Sciences(EXAS) - 2020 Q2 - Quarterly Report
2020-07-31 20:37
Table of Contents | --- | --- | --- | --- | |-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|------------------------------------------- ...
Exact Sciences(EXAS) - 2020 Q2 - Earnings Call Transcript
2020-07-31 11:55
Exact Sciences Corporation (NASDAQ:EXAS) Q2 2020 Earnings Conference Call July 30, 2020 5:00 PM ET Company Participants Megan Jones - Manager, Investor Relations Kevin Conroy - Chairman and Chief Executive Officer Jeff Elliott - Chief Financial Officer Conference Call Participants Brandon Couillard - Jefferies Doug Schenkel - Cowen Brian Weinstein - William Blair Derik de Bruin - Bank of America Patrick Donnelly - Citi Catherine Schulte - Baird Dan Brennan - UBS Dan Arias - Stifel Kevin DeGeeter - Oppenheim ...
Exact Sciences(EXAS) - 2020 Q1 - Earnings Call Transcript
2020-05-07 10:25
Exact Sciences Corp (NASDAQ:EXAS) Q1 2020 Earnings Conference Call May 6, 2020 5:00 PM ET Company Participants Megan Jones - Associate Manager, IR Kevin Conroy - Chairman, President & CEO Jeffrey Elliott - CFO Conference Call Participants Brian Weinstein - William Blair & Company Doug Schenkel - Cowen and Company Derik Bruin - Bank of America Merrill Lynch Patrick Donnelly - Citigroup Daniel Arias - Stifel, Nicolaus & Company Catherine Schulte - Robert W. Baird & Co. Daniel Brennan - UBS Investment Bank Luk ...
Exact Sciences(EXAS) - 2020 Q1 - Quarterly Report
2020-05-07 04:09
Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share EXAS The Nasdaq Stock Market LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-3 ...
Exact Sciences(EXAS) - 2019 Q4 - Annual Report
2020-02-21 21:50
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________________________ FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-35092 | --- | --- | --- | |--------------------------------------------------------- ...
Exact Sciences(EXAS) - 2019 Q4 - Earnings Call Transcript
2020-02-12 13:23
Exact Sciences Corp (NASDAQ:EXAS) Q4 2019 Earnings Conference Call February 11, 2020 5:00 PM ET Company Participants Megan Jones - Manager, IR Kevin Conroy - Chairman, President & CEO Jeff Elliott - CFO Conference Call Participants Derik de Bruin - Bank of America Brian Weinstein - William Blair Brandon Couillard - Jefferies Doug Schenkel - Cowen Daniel Macik - Stifel Amanda Murphy - BTIG Patrick Donnelly - Citi Catherine Schulte - Baird Dan Brennan - UBS Operator Ladies and gentlemen, thank you for standin ...